Literature DB >> 10537776

Choroidal neovascularization in younger patients.

R F Spaide1.   

Abstract

Choroidal neovascularization (CNV) is the most common cause of legal blindness in older adults in the United States. The most common cause for CNV in this age group is age-related macular degeneration, a condition manifesting with drusen (particularly soft drusen) and pigmentary alterations in the macular region. CNV can occur in younger people (< 50 years), who usually do not have conspicuous drusen or pigmentary abnormalities. In this age group CNV may occur as a secondary manifestation of many inherited and acquired conditions such as angioid streaks, high myopia, trauma, choroidal tumors, familial macular dystrophies, and inflammatory retinochoroidopathies. Occasionally, CNV in young people has no apparent antecedent cause, and these cases are termed "idiopathic CNV." This review examines the common reasons for CNV in young adults, with reference to some of the older literature as well as to recently published papers.

Entities:  

Mesh:

Year:  1999        PMID: 10537776     DOI: 10.1097/00055735-199906000-00005

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  15 in total

1.  Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

Authors:  P J Rosenfeld
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

2.  Adhesion failures determine the pattern of choroidal neovascularization in the eye: a computer simulation study.

Authors:  Abbas Shirinifard; James Alexander Glazier; Maciej Swat; J Scott Gens; Fereydoon Family; Yi Jiang; Hans E Grossniklaus
Journal:  PLoS Comput Biol       Date:  2012-05-03       Impact factor: 4.475

3.  [Young woman with loss of vision and metamorphopsia].

Authors:  A Hackstedt; H Thieme; S Walter; T Wecke
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

4.  Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Authors:  T Barth; F Zeman; H Helbig; M-A Gamulescu
Journal:  Int Ophthalmol       Date:  2017-04-19       Impact factor: 2.031

5.  Choroidal neovascularization in 36 eyes of children and adolescents.

Authors:  P Rishi; A Gupta; E Rishi; B J Shah
Journal:  Eye (Lond)       Date:  2013-07-26       Impact factor: 3.775

6.  Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks.

Authors:  Heinrich Heimann; Faik Gelisken; Joachim Wachtlin; Andreas Wehner; Michael Völker; Michael H Foerster; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-10       Impact factor: 3.117

7.  Appearance of pediatric choroidal neovascular membranes on optical coherence tomography angiography.

Authors:  Sally S Ong; S Tammy Hsu; Dilraj Grewal; J Fernando Arevalo; Mays A El-Dairi; Cynthia A Toth; Lejla Vajzovic
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-22       Impact factor: 3.117

8.  Choroidal neovascularization in 111 eyes of children and adolescents.

Authors:  Pukhraj Rishi; Rekha Priya Kalluri Bharat; Ekta Rishi; Muna Bhende; Jyotirmay Biswas; Arshee Ahmed; Sridharan Sudharshan
Journal:  Int Ophthalmol       Date:  2021-08-23       Impact factor: 2.031

9.  Choroidal neovascularization in a patient with Crohn's disease.

Authors:  Giuseppe Casalino; Giuseppe Querques; Federico Corvi; Enrico Borrelli; Giacinto Triolo; Giuseppe Alvise Ramirez; Francesco Bandello
Journal:  Case Rep Ophthalmol       Date:  2014-08-04

10.  The small tellurium-based compound SAS suppresses inflammation in human retinal pigment epithelium.

Authors:  Rima Dardik; Tami Livnat; Gilad Halpert; Shayma Jawad; Yael Nisgav; Shirley Azar-Avivi; Baoying Liu; Robert B Nussenblatt; Dov Weinberger; Benjamin Sredni
Journal:  Mol Vis       Date:  2016-05-28       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.